Mcl-1 expression predicts progression-free survival in chronic lymphocytic leukemia patients treated with pentostatin, cyclophosphamide, and rituximabFarrukh T. Awan, David Lucas|Blood|2008Cited by 69
BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemiaYo-Ting Tsai, David Lucas|Blood Advances|2017Cited by 5